ACOTEC-B (06669) announced that on October 7, 2025, the company's venous intracavitary radiofrequency ablation system received 510(k) market clearance from the U.S. Food and Drug Administration. The system includes the Cedar™ venous intracavitary radiofrequency catheter and venous intracavitary radiofrequency generator, which work together to treat lower limb varicose veins caused by superficial venous reflux. The company has signed a distribution agreement with a member company of the BSC Group for the product's sales in the United States. BSC Group will commence commercialization efforts for this product in the U.S. market in due course.